She started her career in pharmaceutical sales, receiving several national awards during her tenure at both Parke-Davis and Wyeth. She has held several other leadership roles at various companies within the medical device industry, including Cordis Cardiology (Cardinal Health) and FoxHollow Technologies (Medtronic). This rating has improved by 7 over the last 12 months. 65 of employees would recommend working at Bardy Diagnostics to a friend and 61 have a positive outlook for the business. Most recently, Cristina was in charge of market development and sales for the Long-Term Care market at the health technology company MedBridge. Bardy Diagnostics has an overall rating of 3.7 out of 5, based on over 31 reviews left anonymously by employees. In her 6 years at iRhythm Technologies as their first commercial-facing employee, Cristina built the Marketing team and oversaw all the marketing, sales training, and new markets activities, including the launch of their flagship product, the Zio Patch.
BARDY DIAGNOSTICS LOGO PATCH
With over 20 years of sales and marketing experience within the healthcare industry, Cristina brings extensive experience to the Bardy team in the diagnostic cardiac patch monitoring space. In addition, he completed his residency at Northwestern University and a fellowship in cardiology and electrophysiology at Duke University. Bardy earned a BS in physics from Carnegie-Mellon University before completing his MD from Northwestern University Medical School. Bardy holds a faculty position as Clinical Professor of Medicine, Cardiology at the University of Washington and is the Director of the Seattle Institute for Cardiac Research. In addition to serving Bardy Diagnostics, Dr. Bardy’s previous company, Cameron Health, was successfully acquired by Boston Scientific in 2012 for its revolutionary Subcutaneous Implantable Defibrillator (S-ICD) product.
patents issued, all of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. Bardy has also developed technological solutions to patient rhythm problems with over 270 U.S. He has been a researcher and clinician in the field of sudden death and disabling cardiac rhythm disorders for 38 years with over 400 peer-reviewed publications. Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technical perspective.
0 kommentar(er)
